×

Growth Reports

Growth Reports
Report Name

Digital Breast Tomosynthesis Equipment Market Size, Share, Trends, Growth Outlook, and Opportunities to 2030- By Product (2D/3D Combination Mammography Systems, Standalone 3D Mammography Systems), By End-User (Hospitals, Diagnostic Centers, Others), Countries and Companies Report

Digital Breast Tomosynthesis Equipment is projected to register a 14.5% CAGR from 2024 to 2030, driven by North America, Europe, Asia Pacific, Latin America, Middle East, and Africa markets

Published On: February, 2026  |   Report Code: USD00024667  |   No. of Pages: 205

Digital Diagnostics Market Size, Share, Trends, Growth Outlook, and Opportunities to 2030- By Product (Hardware, Software, Services), By Diagnosis (Cardiology, Oncology, Neurology, Radiology, Pathology, Others), By End-User (Hospitals and Clinics, Clinical Laboratories, Others), Countries and Companies Report

Digital Diagnostics is projected to register a 16.1% CAGR from 2024 to 2030, driven by North America, Europe, Asia Pacific, Latin America, Middle East, and Africa markets

Published On: February, 2026  |   Report Code: USD00024668  |   No. of Pages: 205

Dextromethorphan Market Size, Share, Trends, Growth Outlook, and Opportunities to 2030- By Form (Tablets, Syrups, Others), By Application (Common Cold, Flu, Sore Throat, Others), By Distribution Channel (Retail Pharmacy, Hospital Pharmacy, Others), Countries and Companies Report

Dextromethorphan is projected to register a 4.2% CAGR from 2024 to 2030, driven by North America, Europe, Asia Pacific, Latin America, Middle East, and Africa markets

Published On: February, 2026  |   Report Code: USD00024660  |   No. of Pages: 205

Dialysis Concentrate Market Size, Share, Trends, Growth Outlook, and Opportunities to 2030- By Type (Acid Concentrates, Bicarbonate Concentrates, Peritoneal Dialysis Fluid), By Application (Hemodialysis, Peritoneal Dialysis), By Dialysis Site (Hospital, Clinics & Dialysis Centers, Home Dialysis), Countries and Companies Report

Dialysis Concentrate is projected to register a 5.2% CAGR from 2024 to 2030, driven by North America, Europe, Asia Pacific, Latin America, Middle East, and Africa markets

Published On: February, 2026  |   Report Code: USD00024664  |   No. of Pages: 205

Diagnostic Specialty Antibodies Market Size, Share, Trends, Growth Outlook, and Opportunities to 2030- By Type (Monoclonal Antibodies, Polyclonal Antibodies, Recombinant Polyclonal Antibodies), By Application (Hepatitis, Tuberculosis, Dengue, Oncology, HIV, Infectious Disease, Others), By End-User (Hospitals, Diagnostic Laboratories, Others), Countries and Companies Report

Diagnostic Specialty Antibodies is projected to register a 4.9% CAGR from 2024 to 2030, driven by North America, Europe, Asia Pacific, Latin America, Middle East, and Africa markets

Published On: February, 2026  |   Report Code: USD00024663  |   No. of Pages: 205

Differentiated Thyroid Cancer Therapeutics Market Size, Share, Trends, Growth Outlook, and Opportunities to 2030- By Therapy (Chemotherapy, Targeted Therapy, Thyroid Stimulating Hormone, Suppression (THS), Others), Countries and Companies Report

Differentiated Thyroid Cancer Therapeutics is projected to register a 13.8% CAGR from 2024 to 2030, driven by North America, Europe, Asia Pacific, Latin America, Middle East, and Africa markets

Published On: February, 2026  |   Report Code: USD00024665  |   No. of Pages: 205

Digestive Enzymes Market Size, Share, Trends, Growth Outlook, and Opportunities to 2030- By Origin (Animal, Microbial, Plant), By Enzyme Type (Carbohydrase, Protease, Lipase, Others), By Application (Prescription Medicine, Sports Nutrition, Infant Nutrition), Countries and Companies Report

Digestive Enzymes is projected to register a 8.1% CAGR from 2024 to 2030, driven by North America, Europe, Asia Pacific, Latin America, Middle East, and Africa markets

Published On: February, 2026  |   Report Code: USD00024666  |   No. of Pages: 205

Dilated Cardiomyopathy Therapeutic Market Size, Share, Trends, Growth Outlook, and Opportunities to 2030- By Drug Class (Aldosterone antagonists, Angiotensin-converting enzyme (ACE) Inhibitors, Angiotensin II Receptor Blockers, Beta-blockers), Countries and Companies Report

Dilated Cardiomyopathy Therapeutic is projected to register a 3.9% CAGR from 2024 to 2030, driven by North America, Europe, Asia Pacific, Latin America, Middle East, and Africa markets

Published On: February, 2026  |   Report Code: USD00024671  |   No. of Pages: 205